Personalised health research

Personalised health

Our world leading personalised health research paves the way for uniquely treating individuals based on their genetics and other health data.

Our vision is a world where every patient receives the right drugs at optimal doses, maximising tolerability, and pre-empting and managing adverse drug reactions. This personalised approach maximises the efficacy of treatment while improving patient quality of life.

World leading research at the University of Liverpool has significant implications across the whole spectrum of pharmaceutical production and delivery. Most importantly it benefits the wellbeing of patients and society as a whole.

In 2018, our Department of Molecular and Clinical Pharmacology received a Queen’s Anniversary Prize in recognition of its work to improve the safety and effectiveness of medicines.

Further information for staff >

Research activities

Little girl in hospital bed

Paediatric medicine: improving outcomes

Researchers are working on finding the best choice and optimal dose of medicines for children.

hospital patient

Managing toxicity when treating cancer

Researching the newest next-generation drugs to treat patients with more advanced, malignant cancers and dealing with the toxicity.

woman having a mammogram

Cancer testing and health inequalities

Research into the socioeconomic factors affect genetic testing uptake.

abstract image of a virus

At the forefront of HIV healthcare

An award-winning and Interaction Checker website and app, is helping healthcare professionals to safely prescribe drugs patients.

Human eye

Revolutionising eye cancer treatment

Identifying the role of a specific protein that can help prevent the survival and spread of eye cancer.

Warfarin medicine

Delivering the correct dosages of warfarin

Personalising the dose of warfarin to the patient can improve its the effectiveness.

The Liverpool Advantage - expertise and collaboration


Developing acute pancreatitis drug

A partnership involving the University and Cypralis has been granted a new Early Stage Award worth £300K to develop new compounds to treat acute pancreatitis.


MRC Centre for Drug Safety Science

Maximising benefits and reducing risks of new and existing medicine through this unique in the UK centre.

Centre for Genomics Research

Centre for Genomic Research

The Centre for Genomic Research  facilitates cost-effective access to multiplatform sequencing and array technologies for researchers worldwide.

Meet some of our leading academics in personalised health research:

Professor Sir Munir Pirmohamed

Professor Sir Munir Pirmohamed

Professor, Molecular and Clinical Pharmacology

Professor Robert Sutton

Professor Robert Sutton

Professor of Surgery, Molecular and Clinical Cancer Medicine

Professor Sarah Coupland

Professor Sarah Coupland

George Holt Chair in Pathology, Honorary Consultant Histopathologist

Professor Andrew Morris

Professor Andrew Morris

Chair in Statistical Genetics

Prof Paula Williamson

Professor Paula Williamson

Professor of Medical Statistics

Anna Olsson-Brown

Dr Anna Olsson-Brown

Molecular and Clinical Pharmacology

Dr Lauren Walker

Dr Lauren Walker

Molecular and Clinical Pharmacology

Prof Michael Beresford

Professor Michael Beresford

Brough Chair, Professor of Child Health

Francesco Falciani

Professor Francesco Falciani

Professor, Functional and Comparative Genomics

Dr Vincent Yip

Dr Vincent Yip

Molecular and Clinical Pharmacology

Dan Hawcutt

Dr Dan Hawcutt

Senior Lecturer Paediatric Clinical Pharmacology

Saye Khoo

Professor Saye Khoo

Molecular and Clinical Pharmacology